neurnonia caused by Pneumocystis carinii is bePcoming an increasingly frequent clinical p m b lem. European physicians have known for a long time that this disease mainly affects premature and debilitated infants or children with congenital immunologic disorders.' In the United States, during the last decade, P carinii pneumonia has been reported most frequently in patients with various imFor editorial comment, see page 547 munologic disorders. Among patients who seem predisposed to develop this form of pneumonia are these with neoplasms of the hematopoietic, lymphoreticular, and other systems and who usually are receiving steroid or cytotoxic drugs, those with collagen diseases who are treated with steroids, those who have received kidney and heart transplants and who are treated with immunosuppressive drugs, and those with immunoglobin deficiencies, such as thymic alymphoplasia.
Since effective therapy for this once fatal disease is now a~a i l a b l e ,~.~ it is important to make a diagnosis of P carinii pneumonia early. We report our experience with the technique of transbronchoscopic lung biopsy in obtaining material to make this diagnosis. The diagnosis of P carinii pneumonia was made in seven patients.
The technique of transbronchoscopic lung biopsy, a satisfactory method of obtaining pulmonary tissue from patients with diffuse pulmonary diseases,4,5 was used in 525 such patients. Among this group of 525, there were 7 patients in whom the diagnosis of P curinii pneumonia was made by this diagnostic procedure ( Table 1 ) . Two of these patients had Hodgkin's disease, two had received renal transplants, one had chronic lymphocytic leukemia, one had polycythemia mbra Vera, and one had acute lymphocytic leukemia. Six of the seven patients had been on immunosuppressive therapy at the time pneumonia developed.
Transbronchoscopic lung biopsy is performed through a standard rigid bronchoscope. Topical anesthesia is preferred, because most patients suspected of having P curinif pneumonia are too ill to tolerate general anesthesia; indeed, our patients at the time biopsy was required generally were critically ill. A bronchoscopic examination is made in the usual manner. Then, flexible forceps having a rectangular cup approximately 2 by 4 mm or a circumference of approximately size 7 F (Fig 1 ) are carefully inserted into selected segmental bronchi. When the forceps become engaged in a peripheral bronchus, so that with respiratory motion the forceps are pulled downward and pushed outward, the jaws are opened during inhalation and closed during exhalation. Pulmonary tissue usually can be pulled away easily. We attempt to obtain at least three biopsy specimens, each from a different pulmonary segment; we have taken as many as five pieces of tissue.
In addition to the biopsies of pulmonary tissue, bronchial secretions were collected from all seven patients, and sputum was collected from two patients. Bronchial brushings were obtained in one patient. 
RESULTS
than 15 percent ), but constant intrathoracic suction
Microscopic Findings
Transbronchoscopic lung biopsy provided a positive diagnosis of P carinii in all seven patients. Moreover, no other case of pneumocystis pneumonia was discovered by any additional means, including autopsy, among the total 525 patients with diffuse pulmonary diseases who had transbronchoscopic lung biopsy. In other words, there were no falsenegative biopsies.
The bronchial secretions contained demonstrable P carinii organisms in two of the seven specimens examined. In one of the five specimens in which the bronchial secretions contained no demonstrable organisms, results of bronchial brushing were also negative.
The sputum in each of two cases was negative for P carinii.
The patients subsequently were treated with pentamidine isethionate daily (dose, 4 mglkg), by either intramuscular or intravenous injection. The periods of treatment are given in Table 1 . Two patients are still living 15 and U) months later; these two patients were treated for 7 and 14 days. A third patient received pentamidine for ten days, recovered from the infection, and, to date, has sunrived for eight months.
Patient 1 ( Table 1 ) had pneumonia that persisted in spite of receiving pentamidine for 14 days. Bronchoscopy and lung biopsy, therefore, were repeated. The histologic diagnosis was "active interstitial pneumonitis and fibrosis," but the presence of P carinii was not demonstrable in the second biopsy. She died after receiving pentamidine for 18 days; death was attributed to respiratory failure associated with cytomegalic inclusion disease. Autopsy confirmed the finding of the second biopsy that P carinii had been eliminated after the course of pentamidine therapy.
Complications of Biopsy
In three of the seven patients pneumothorax developed after biopsy ( Table 1 ) . In two of the three patients the pneumothorax was small (less by catheter or S-needle was used for 24 to 48 hours in all three patients because of diminished pulmonary reserve. In none of the patients did the procedure appear to be a significant factor in the deterioration of the pulmonary status. It should be noted from Table 1 that two of the three pneumothoraces occurred in patients who ultimately became longterm survivors.
Even so, the occurrence of pneumothorax in three of the seven patients is disconcerting. On the other hand, they were gravely ill and it was essential to make a diagnosis. Among the total group of 525 cases in which transbronchoscopic lung biopsy had been performed for various pulmonary diseases, the incidence of pneumothorax was 14 percent. In the most recent 375 of the 525 cases, the incidence has been only 11 percent. The present sample of seven patients is too small to permit one to conclude that this method of biopsy is more hazardous in patients with P carinii pneumonia than it is in those with other diffuse pulmonary diseases.
Bleeding has been no problem in any of these seven cases and has not been a serious problem in any of the total group of patients with transbronchoscopic lung biopsy. If the endoscopist observes more than a very small amount of blood, he can insert narrow surgical gauze tape through the bronchoscope into the segmental bronchus from which the biopsy was taken. This can be left for two or three minutes, then removed. This maneuver has been successful in stopping bleeding in every instance in which it has been used. The ability to control bleeding so simply is a distinct advantage of the transbronchoscopic biopsy as compared with the percutaneous needle biopsy.
In 1909, Chagass observed pneumdcystis organisms in the lungs of guinea pigs that were infected with Typanosoma cruzi, and in 1910, Carini7 reported the presence of these organisms in lungs of rats that were infected with Typanosoma lewisi. In 1912, the carinii to these organisms. Since then there have been many reports of pneumonia due to P carinii. Various methods have been used in attempts to demonstrate this organism, but it is not always easy to obtain material safely for diagnosis in a sick patient. P carinii has been detected in s p u t~r n~~~~ and, in certain cases, in aspirates from the nasopharynx," hyp~pharynx,'~.'~ trachea,13 and bronhi.'^,'^ In the experience of most groups, however, attempts to diagnose P carinii pneumonia by the above methods have been unsuccessful.15~16 Open lung biopsy is a good method of obtaining tissue for demonstration of P carinii,17-l9 but patients with the disease are frequently too ill to withstand this procedure. Transthoracic lung biopsy15,16,20e21 and transthoracic lung a~p i r a t i o n~~.~~ also have been used. Needle aspiration and needle biopsy have been used to obtain P carinii cysts but attempts to identify them occasionally have failed in those patients later proved by other methods to have P carinii p n e~r n o n i a .~~,~~ A complement-fixation test is reportedly helpful in identifying patients who have been infected with P ~a r i n i i ,~~.~~ but this serologic test has been used infrequently in this country. Results have been disappointing, probably because of the severe suppression of the immune response in most of these patient~.~'
Rarely the organism has been found in other tissues. Zandanel128 reported several cases in which P carinii was found in the peripheral blood. A skin test for the infection has been used,29 but its reliability has not been adequately evaluated.' P carinii has been found in the peripheral and study of posterior iliac crest bone marrow aspirate (taken antemortem) revealed P carinii in a case of systemic dissemination of this organism. The use of an immunofluorescent technique for identification of specific irnmunofluorescent bodies in the sputum from patients suspected of having P carinii pneumonia has been reported.s2 This method might provide a means of diagnosis that would not require lung biopsy, but it needs further evaluation.
Bronchial brushing has been used as a method for making a diagnosis of P carinii pneumonia. A reportt6 published in 1969 described poor results, but a recent report? is more encouraging.
Various methods for the detection of P carinii in the lung thus have been reported. Apart from transbronchoscopic or open lung biopsy, none of these has been uniformly successful. We have encountered no case in which transbronchoscopic lung biopsy was falsely negative for P carinii pneumonia, whereas sputum examination was negative for pneumocystis in each of two patients whose sputum was studied. and bronchial secretions obtained at bronchoscopy were negative for Pneumocystis in five of the seven patients. Bronchial brushings were negative in the one case in which they were obtained.
